Rapiblyk 280 MG Injection

RxCUI: 2712079
RxNorm name: Rapiblyk 280 MG Injection
Display name: Rapiblyk 280 MG Injection
Full name: Rapiblyk 280 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
RAPIBLYK	LANDIOLOL	AOP Orphan Pharmaceuticals GmbH	27e7f20f-78a4-f1a9-e063-6394a90ae465	2026-06-19	Warnings, Adverse reactions	Exact identifier rxcui: 2712079

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
27e7f20f-78a4-f1a9-e063-6394a90ae465	Rapiblyk 280 MG Injection [PSN] · landiolol 280 MG Injection [Rapiblyk] [SBD] · Rapiblyk 280 MG (equivalent to landiolol HCl 300 MG) Injection [SY]	3	106	These highlights do not include all the information needed to use RAPIBLYK safely and effectively. See full prescribing information for RAPIBLYK. RAPIBLYK (landiolol) for injection, for intravenous use Initial U.S. Approval: 2024	20260427
411b0949-3a5e-2a4b-e063-6394a90abcbf	Rapiblyk 280 MG Injection [PSN] · landiolol 280 MG Injection [Rapiblyk] [SBD] · Rapiblyk 280 MG (equivalent to landiolol HCl 300 MG) Injection [SY]	3	6	These highlights do not include all the information needed to use RAPIBLYK ® safely and effectively. See full prescribing information for RAPIBLYK. RAPIBLYK (landiolol) for injection, for intravenous use Initial U.S. Approval: 2024	20260213